We are live on !
Find out more
John Overdeck Two Sigma Investments
AUM
$138B
Turnover
29.02%
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter Est. Return
+21.14%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$138B
AUM Growth
+$14.2B
(+11%)
Cap. Flow
-$5.38B
Cap. Flow % of AUM
Cap. Flow %
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
8.28%
Holding
5,589
New
1,050
Increased
1,919
Reduced
1,756
Closed
572
Avg Time Held
Equity + Options
1.4
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.2
years
Avg Time Held Equity only
1.7
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$753M |
| 2 |
Boston Scientific
BSX
|
+$540M |
| 3 |
Dow Inc
DOW
|
+$485M |
| 4 |
Wells Fargo
WFC
|
+$457M |
| 5 |
Goldman Sachs
GS
|
+$378M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.32B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$787M |
| 4 |
Sandisk
SNDK
|
+$744M |
| 5 |
Dell
DELL
|
+$688M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 15.22% |
| 3 | Miscellaneous | 12.05% |
| 4 | Healthcare | 11.94% |
| 5 | Industrials | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Meritage Homes
MTH
$3.86B
| $154M | 0.11% |
1,839,080
+438,051
| +31% | +$29.9M |
2024 Q4
6 quarters
|
|
202
Hecla Mining
HL
$10.3B
| $154M | 0.11% |
9,979,016
+5,565,771
| +126% | +$97.8M |
2024 Q1
9 quarters
|
|
203
Viking Therapeutics
VKTX
$3.2B
| $154M | 0.11% |
3,937,414
-494,728
| -11% | -$16M |
2025 Q1
5 quarters
|
|
204
Camden Property Trust
CPT
$11.4B
| $152M | 0.11% |
1,324,625
+197,354
| +18% | +$21M |
2022 Q1
17 quarters
|
|
205
Viking Holdings
VIK
$37.3B
| $151M | 0.11% |
1,446,534
-3,126,216
| -68% | -$270M |
2024 Q3
7 quarters
|
|
206
Hinge Health
HNGE
$8B
| $150M | 0.11% |
1,807,895
+1,424,016
| +371% | +$77.3M |
2025 Q2
4 quarters
|
|
207
Tapestry
TPR
$23.8B
| $148M | 0.11% |
1,008,180
+420,401
| +72% | +$60.2M |
2024 Q2
8 quarters
|
|
208
DocuSign
DOCU
$14B
| $147M | 0.11% |
3,301,509
+1,531,101
| +86% | +$71.8M |
2025 Q3
3 quarters
|
|
209
State Street
STT
$45.5B
| $146M | 0.11% |
858,446
+239,611
| +39% | +$36.9M |
2024 Q1
9 quarters
|
|
210
Skyworks Solutions
SWKS
$18.7B
| $146M | 0.11% |
2,146,126
-1,326,877
| -38% | -$90.3M |
2021 Q3
19 quarters
|
|
211
Essential Properties Realty Trust
EPRT
$5.64B
| $144M | 0.1% |
4,822,946
-363,042
| -7% | -$11.3M |
2022 Q1
17 quarters
|
|
212
Cleveland-Cliffs
CLF
$6.91B
| $143M | 0.1% |
15,200,394
+1,278,398
| +9% | +$14.1M |
2025 Q1
5 quarters
|
|
213
Hartford Financial Services
HIG
$36.6B
| $143M | 0.1% |
1,076,246
+1,039,428
| +2,823% | +$139M |
2025 Q2
4 quarters
|
|
214
W.R. Berkley
WRB
$28B
| $142M | 0.1% |
2,013,358
+1,740,369
| +638% | +$117M |
2020 Q3
23 quarters
|
|
215
Timken Company
TKR
$7.79B
| $142M | 0.1% |
975,764
-1,655
| -0.2% | -$199K |
2021 Q3
19 quarters
|
|
216
Vertex Pharmaceuticals
VRTX
$127B
| $142M | 0.1% |
285,000
-93,146
| -25% | -$41.3M |
2025 Q4
2 quarters
|
|
217
Las Vegas Sands
LVS
$24.6B
| $141M | 0.1% |
3,054,162
-1,117,699
| -27% | -$58M |
2026 Q1
1 quarter
|
|
218
monday.com
MNDY
$3.82B
| $139M | 0.1% |
1,914,280
-77,410
| -4% | -$5.67M |
2022 Q4
14 quarters
|
|
219
HDFC Bank
HDB
$123B
| $138M | 0.1% |
5,359,127
+1,208,588
| +29% | +$30.3M |
2025 Q1
5 quarters
|
|
220
HP
HPQ
$27.1B
| $138M | 0.1% |
6,303,159
+4,211,053
| +201% | +$93.2M |
2025 Q4
2 quarters
|
|
221
Revolution Medicines
RVMD
$38.1B
| $138M | 0.1% |
737,697
-821,110
| -53% | -$120M |
2025 Q3
3 quarters
|
|
222
Edwards Lifesciences
EW
$49.9B
| $138M | 0.1% |
1,521,899
+470,364
| +45% | +$39.4M |
2021 Q1
21 quarters
|
|
223
B2Gold
BTG
$7.01B
| $136M | 0.1% |
36,461,952
-6,601,948
| -15% | -$30.3M |
2018 Q2
32 quarters
|
|
224
BlackBerry
BB
$4.73B
| $136M | 0.1% |
10,733,152
+10,384,331
| +2,977% | +$72.5M |
2024 Q3
7 quarters
|
|
225
TG Therapeutics
TGTX
$8.26B
| $136M | 0.1% |
2,468,971
+926,659
| +60% | +$37.9M |
2022 Q1
17 quarters
|
|
Similar funds
John Overdeck's Q2 2026 Portfolio in Review
As of Q2 2026, John Overdeck held 5,589 positions worth $138B, up 11% from $124B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
John Overdeck withdrew a net $5.38B in Q2 2026, closing 572 positions and reducing 1,756 holdings. Its most notable exit was State Street Technology Select Sector SPDR ETF, an estimated $172M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Miscellaneous.
Against the trend, John Overdeck opened a new position in Intuit worth $564M.
- John Overdeck's largest Q2 2026 buy was Intuit: 2,161,507 shares worth $564M.
- John Overdeck added most to Boston Scientific in Q2 2026, an estimated $540M increase.
- John Overdeck's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.32B.
- John Overdeck fully exited State Street Technology Select Sector SPDR ETF in Q2 2026, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 8.3% of its $138B portfolio in Q2 2026.
- John Overdeck opened 1,050 new positions and closed 572 in Q2 2026.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $138B.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.